AREV Life Sciences Global Corp. engages in the production and development of natural health and cannabis infused products. The company is headquartered in Coquitlam, British Columbia. The company produces ingredients and formulates therapeutic interventions in clinical nutrition, supplements, topicals and rational drug design, based on science. Its nutraceutical product formulations are sold under its BARE and Wright and Well brands. Its BARE and Wright and Well Brands of finished products include natural health products, including cannabidiol (CBD)-infused products such as Canna-Mulsion and NaturVax, an anti-viral supplement; NaturRelax, a natural Sleep Aid; Natur Relief, an anti-inflator and pain relief product, and a line of CBD skincare products and medicinal oils and edibles. Its Ready-to-Use Therapeutic Food (RUTF) for Severe Acute Malnutrition (SAM), with its branded RUTF known as SUS-TAINN (Superior Utility Supplementation Therapeutic Agent for Indicated Nutritional Needs), and RESTORE is under development.
根据最新的财务报表(Form-10K),AREV Life Sciences Global Corp 的总资产为 $0,净损失为 $-1
AREVF 的关键财务比率是什么?
AREV Life Sciences Global Corp 的流动比率是 0,净利 margin 为 0,每股销售为 $0。
AREV Life Sciences Global Corp 的收入按细分市场或地理位置如何划分?
AREV Life Sciences Global Corp 最大收入来源是 Banking and Related Activities,在最近的收益报告中收入为 33,368,000。就地区而言, United States 是 AREV Life Sciences Global Corp 的主要市场,收入为 33,368,000。
AREV Life Sciences Global Corp 是否盈利?
不,根据最新的财务报表,AREV Life Sciences Global Corp 的净损失为 $-1